Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Demaria

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Cancers|June 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical TrialMelanie Spears, Michael Lock, Brian Yaremko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast CancerSilvia C Formenti, Percy Lee, Sylvia Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Nature Medicine|November 7, 2018
Radiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C Formenti, Nils-Petter Rudqvist, Encouse Golden, et al.
Journal of Translational Medicine|June 3, 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Journal of the National Cancer Institute|December 11, 2024
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesisAitziber Buqué, Norma Bloy, Giulia Petroni, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Cancers|June 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical TrialMelanie Spears, Michael Lock, Brian Yaremko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast CancerSilvia C Formenti, Percy Lee, Sylvia Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Nature Medicine|November 7, 2018
Radiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C Formenti, Nils-Petter Rudqvist, Encouse Golden, et al.
Journal of Translational Medicine|June 3, 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Journal of the National Cancer Institute|December 11, 2024
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesisAitziber Buqué, Norma Bloy, Giulia Petroni, et al.
Pageof 16